278 related articles for article (PubMed ID: 35168302)
21. Rectal administration of low-dose diclofenac does not reduce post-endoscopic retrograde cholangiopancreatography pancreatitis: a propensity score matching analysis.
Sakai H; Iwai N; Sakagami J; Okuda T; Ohara T; Hattori C; Taniguchi M; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Dohi O; Yasuda H; Konishi H; Itoh Y
Surg Endosc; 2023 Apr; 37(4):2698-2705. PubMed ID: 36443561
[TBL] [Abstract][Full Text] [Related]
22. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial.
Mok SRS; Ho HC; Shah P; Patel M; Gaughan JP; Elfant AB
Gastrointest Endosc; 2017 May; 85(5):1005-1013. PubMed ID: 27816497
[TBL] [Abstract][Full Text] [Related]
23. The Incidence and Severity of Post-ERCP Pancreatitis in Patients Receiving Standard Administration of NSAIDs: a Systematic Review and Meta-analysis.
Kang X; Guo X; Chen Z; Zhou Z; Luo H; Lu Y; Lou L; Guo X; Pan Y
J Gastrointest Surg; 2022 Nov; 26(11):2380-2389. PubMed ID: 35941494
[TBL] [Abstract][Full Text] [Related]
24. Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using Temporary Pancreatic Stents Versus Rectal Nonsteroidal Anti-inflammatory Drugs: A Randomized Controlled Trial.
Koshitani T; Konaka Y; Ohishi T; Yasuda T; Morinushi T; Mita M; Masuda M; Nakano K; Fuki S; Nakagawa S
Pancreas; 2022 Jul; 51(6):663-670. PubMed ID: 36099496
[TBL] [Abstract][Full Text] [Related]
25. Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.
Tomoda T; Kato H; Ueki T; Akimoto Y; Hata H; Fujii M; Harada R; Ogawa T; Wato M; Takatani M; Matsubara M; Kawai Y; Okada H
Gastroenterology; 2019 May; 156(6):1753-1760.e1. PubMed ID: 30772342
[TBL] [Abstract][Full Text] [Related]
26. Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
Cheon YK
Korean J Intern Med; 2013 Mar; 28(2):141-8. PubMed ID: 23525264
[TBL] [Abstract][Full Text] [Related]
27. Network meta-analysis of prophylactic pancreatic stents and non-steroidal anti-inflammatory drugs in the prevention of moderate-to-severe post-ERCP pancreatitis.
Dubravcsik Z; Hritz I; Keczer B; Novák P; Lovász BD; Madácsy L
Pancreatology; 2021 Jun; 21(4):704-713. PubMed ID: 33926821
[TBL] [Abstract][Full Text] [Related]
28. Can Rectal Diclofenac Prevent Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
Lua GW; Muthukaruppan R; Menon J
Dig Dis Sci; 2015 Oct; 60(10):3118-23. PubMed ID: 25757446
[TBL] [Abstract][Full Text] [Related]
29. Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde cholangiopancreatography pancreatitis.
Agarwal A; Mahapatra SJ; Sethia R; Agarwal S; Elhence A; Mohta S; Gunjan D; Garg PK
Indian J Gastroenterol; 2023 Jun; 42(3):370-378. PubMed ID: 37160838
[TBL] [Abstract][Full Text] [Related]
30. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
[TBL] [Abstract][Full Text] [Related]
31. NSAIDs do not reduce severity among post-ERCP pancreatitis patients.
El Kurdi B; Imam Z; Abonofal A; Babar S; Shah P; Pannala R; Papachristou G; Echavarria J; Pisipati S; Jahangir S; Rajalingamgari P; Chang YH; Singh VP
Pancreatology; 2024 Feb; 24(1):14-23. PubMed ID: 37981523
[TBL] [Abstract][Full Text] [Related]
32. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis.
Rustagi T; Njei B
Pancreas; 2015 Aug; 44(6):859-67. PubMed ID: 26168316
[TBL] [Abstract][Full Text] [Related]
33. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
Patai Á; Solymosi N; Mohácsi L; Patai ÁV
Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
[TBL] [Abstract][Full Text] [Related]
34. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial.
Elmunzer BJ; Serrano J; Chak A; Edmundowicz SA; Papachristou GI; Scheiman JM; Singh VK; Varadarajulu S; Vargo JJ; Willingham FF; Baron TH; Coté GA; Romagnuolo J; Wood-Williams A; Depue EK; Spitzer RL; Spino C; Foster LD; Durkalski V;
Trials; 2016 Mar; 17(1):120. PubMed ID: 26941086
[TBL] [Abstract][Full Text] [Related]
35. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
[TBL] [Abstract][Full Text] [Related]
36. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
[No Abstract] [Full Text] [Related]
37. Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?
Yang D; Draganov PV
World J Gastroenterol; 2012 Aug; 18(31):4082-5. PubMed ID: 22919238
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial.
Sotoudehmanesh R; Ali-Asgari A; Khatibian M; Mohamadnejad M; Merat S; Sadeghi A; Keshtkar A; Bagheri M; Delavari A; Amani M; Vahedi H; Nasseri-Moghaddam S; Sima A; Eloubeidi MA; Malekzadeh R
Endoscopy; 2019 Oct; 51(10):915-921. PubMed ID: 31454851
[TBL] [Abstract][Full Text] [Related]
39. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
[TBL] [Abstract][Full Text] [Related]
40. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists.
Avila P; Holmes I; Kouanda A; Arain M; Dai SC
Gastrointest Endosc; 2020 Mar; 91(3):568-573.e2. PubMed ID: 31743690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
